Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702
- Citation:
- JCO vol 38 (no. 15_suppl) 4003
- Meeting Instance:
- ASCO 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3430
- Pharmas:
- Pfizer
- Grants:
- U10CA180821, U10CA180882; U10CA180863 (CCTG); UG1CA233196, U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);
- Corr. Author:
- Authors:
- Jeffrey A. Meyerhardt Qian Shi Charles S. Fuchs Donna Niedzwiecki Tyler Zemla Priya Kumthekar Katherine A. Guthrie Felix Couture Philip Kuebler Johanna C. Bendell Pankaj Kumar Dequincy Lewis Benjamin Tan Monica Bertagnolli Axel Grothey Howard S. Hochster Richard M. Goldberg Alan Venook Charles Blanke Anthony F. Shields
- Networks:
- CA136, HEARTLAND, LAPS-CT018, LAPS-IL036, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-OH007, OR013, SCOR
- Study
- CALGB-80702
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: